My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 35

    1.

    Effect of cigarette smoking on quality of life in small cell lung cancer patients.

    Chen J, Qi Y, Wampfler JA, Jatoi A, Garces YI, Busta AJ, Mandrekar SJ, Yang P.

    Eur J Cancer. 2012 Jan 12. [Epub ahead of print]

    PMID:
    22244802
    [PubMed - as supplied by publisher]

    Related citations

    2.

    A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer.

    Kawaguchi T, Takada M, Ando M, Okishio K, Atagi S, Fujita Y, Tomizawa Y, Hayashihara K, Okano Y, Takahashi F, Saito R, Matsumura A, Tamura A.

    Eur J Cancer. 2012 Mar;48(5):672-7. Epub 2011 Dec 13.

    PMID:
    22172569
    [PubMed - in process]

    Related citations

    3.

    A phase II study of ¹⁸F-fluorodeoxyglucose PET-CT in non-small cell lung cancer patients receiving erlotinib (Tarceva); objective and symptomatic responses at 6 and 12 weeks.

    O'Brien ME, Myerson JS, Coward JI, Puglisi M, Trani L, Wotherspoon A, Sharma B, Cook G, Ashley S, Gunapala R, Chua S, Popat S.

    Eur J Cancer. 2012 Jan;48(1):68-74. Epub 2011 Nov 24.

    PMID:
    22119198
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    Outcome, quality of life and cognitive function of patients with brain metastases from non-small cell lung cancer treated with whole brain radiotherapy combined with gefitinib or temozolomide. A randomised phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 70/03).

    Pesce GA, Klingbiel D, Ribi K, Zouhair A, von Moos R, Schlaeppi M, Caspar CB, Fischer N, Anchisi S, Peters S, Cathomas R, Bernhard J, Kotrubczik NM, D'Addario G, Pilop C, Weber DC, Bodis S, Pless M, Mayer M, Stupp R.

    Eur J Cancer. 2012 Feb;48(3):377-84. Epub 2011 Nov 15.

    PMID:
    22093943
    [PubMed - indexed for MEDLINE]

    Related citations

    5.

    Retreatment with erlotinib: Regain of TKI sensitivity following a drug holiday for patients with NSCLC who initially responded to EGFR-TKI treatment.

    Becker A, Crombag L, Heideman DA, Thunnissen FB, van Wijk AW, Postmus PE, Smit EF.

    Eur J Cancer. 2011 Nov;47(17):2603-6. Epub 2011 Jul 23.

    PMID:
    21784628
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Establishing an EGFR mutation screening service for non-small cell lung cancer - sample quality criteria and candidate histological predictors.

    Leary AF, Castro DG, Nicholson AG, Ashley S, Wotherspoon A, O'Brien ME, Popat S.

    Eur J Cancer. 2012 Jan;48(1):61-7. Epub 2011 Oct 27.

    PMID:
    22036089
    [PubMed - indexed for MEDLINE]

    Related citations

    7.

    A double-blind, randomised, placebo-controlled phase III intergroup study of gefitinib in patients with advanced NSCLC, non-progressing after first line platinum-based chemotherapy (EORTC 08021/ILCP 01/03).

    Gaafar RM, Surmont VF, Scagliotti GV, Van Klaveren RJ, Papamichael D, Welch JJ, Hasan B, Torri V, van Meerbeeck JP; EORTC Lung Cancer Group and the Italian Lung Cancer Project.

    Eur J Cancer. 2011 Oct;47(15):2331-40. Epub 2011 Jul 28.

    PMID:
    21802939
    [PubMed - indexed for MEDLINE]

    Related citations

    8.

    Systemic treatment of non-small-cell lung cancer.

    Lal R, Enting D, Kristeleit H.

    Eur J Cancer. 2011 Sep;47 Suppl 3:S375-7. Review. No abstract available.

    PMID:
    21944021
    [PubMed - indexed for MEDLINE]

    Related citations

    9.

    Review of the incidence, prevalence, mortality and causative factors for lung cancer in Europe.

    O'Connor SJ.

    Eur J Cancer. 2011 Sep;47 Suppl 3:S346-7. Review. No abstract available.

    PMID:
    21944010
    [PubMed - indexed for MEDLINE]

    Related citations

    10.

    Basic science of lung cancer.

    Kristeleit H, Enting D, Lai R.

    Eur J Cancer. 2011 Sep;47 Suppl 3:S319-21. No abstract available.

    PMID:
    21943998
    [PubMed - indexed for MEDLINE]

    Related citations

    11.

    Management of early-stage non-small-cell lung cancer (NSCLC).

    Le Chevalier T.

    Eur J Cancer. 2011 Sep;47 Suppl 3:S292-3. No abstract available.

    PMID:
    21943988
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Small cell lung cancer: new clinical recommendations and current status of biomarker assessment.

    Planchard D, Le Péchoux C.

    Eur J Cancer. 2011 Sep;47 Suppl 3:S272-83. Review.

    PMID:
    21943984
    [PubMed - indexed for MEDLINE]

    Related citations

    13.

    Second-line treatment options in advanced non-small cell lung cancer.

    de Marinis F, Ricciardi S.

    Eur J Cancer. 2011 Sep;47 Suppl 3:S258-71. Review. No abstract available.

    PMID:
    21943983
    [PubMed - indexed for MEDLINE]

    Related citations

    14.

    2010 Consensus on Lung Cancer, new clinical recommendations and current status of biomarker assessment--first-line therapy.

    Gridelli C, Rossi A, Maione P.

    Eur J Cancer. 2011 Sep;47 Suppl 3:S248-57. Review. No abstract available.

    PMID:
    21943982
    [PubMed - indexed for MEDLINE]

    Related citations

    15.

    Lung cancer screening.

    van Klaveren RJ.

    Eur J Cancer. 2011 Sep;47 Suppl 3:S147-55. Review. No abstract available.

    PMID:
    21943968
    [PubMed - indexed for MEDLINE]

    Related citations

    16.

    Variation in surgical resection for lung cancer in relation to survival: population-based study in England 2004-2006.

    Riaz SP, Lüchtenborg M, Jack RH, Coupland VH, Linklater KM, Peake MD, Møller H.

    Eur J Cancer. 2012 Jan;48(1):54-60. Epub 2011 Aug 24.

    PMID:
    21871792
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    EW-7195, a novel inhibitor of ALK5 kinase inhibits EMT and breast cancer metastasis to lung.

    Park CY, Son JY, Jin CH, Nam JS, Kim DK, Sheen YY.

    Eur J Cancer. 2011 Nov;47(17):2642-53. Epub 2011 Aug 16.

    PMID:
    21852112
    [PubMed - indexed for MEDLINE]

    Related citations

    18.

    IL-20 is epigenetically regulated in NSCLC and down regulates the expression of VEGF.

    Baird AM, Gray SG, O'Byrne KJ.

    Eur J Cancer. 2011 Aug;47(12):1908-18. Epub 2011 May 10.

    PMID:
    21565488
    [PubMed - indexed for MEDLINE]

    Related citations

    19.

    Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study.

    Wanders R, Steevens J, Botterweck A, Dingemans AM, Reymen B, Baardwijk A, Borger J, Bootsma G, Pitz C, Lunde R, Geraedts W, Lambin P, De Ruysscher D.

    Eur J Cancer. 2011 Dec;47(18):2691-7. Epub 2011 Jul 4.

    PMID:
    21733675
    [PubMed - indexed for MEDLINE]

    Related citations

    20.

    Swedish lung cancer radiation study group: predictive value of histology for radiotherapy response in patients with non-small cell lung cancer.

    Holgersson G, Bergström S, Bergqvist M, Nyman J, Hoye E, Helsing M, Friesland S, Holgersson M, Birath E, Ekman S, Blystad T, Ewers SB, Mörth C, Löden B, Henriksson R.

    Eur J Cancer. 2011 Nov;47(16):2415-21. doi: 10.1016/j.ejca.2011.06.011. Epub 2011 Jul 2.

    PMID:
    21726999
    [PubMed - indexed for MEDLINE]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk